Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMAZE 10 trial of once-weekly subcutaneous NNC0487-0111 in Japanese adults with overweight or obesity
jRCT2031260478Recruiting
- Sponsor
- Novo Nordisk
- Start
- Sep 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised trial in Overweight and obesity comparing NNC0487-0111 with Placebo (2 arms). Primary endpoint: Relative change in body weight from baseline to end of treatment. Started Sep 2026; status: recruiting.
02
Drugs
amycretin
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on jRCT2031260478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260478.